Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study

Medicine and Dentistry

• Cohort Analysis 100%
• Non-Alcoholic Fatty Liver Disease 100%
• Nonalcoholic Fatty Liver 45%
• Cardiovascular System 36%
• Hazard Ratio 27%
• Medical Examination 9%
• Proportional Hazards Model 9%
• High Risk Population 9%

Biochemistry, Genetics and Molecular Biology

• Cohort Study 100%
• Normal Human 50%
• All Cause Mortality 50%
• Cardiovascular Mortality 50%
• High Risk Population 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Cohort Study 100%
• Fatty Liver 100%
• Nonalcoholic Fatty Liver 45%
• Normal Human 9%
• Cause of Death 9%